- All > Medicine Access and Rational Use > Antimicrobial Drug Resistance
- All > Medicine Access and Rational Use > Rational Use
- Keywords > drug-resistant tuberculosis - diagnosis and management
- Keywords > Drug-resistant tuberculosis (DR-TB)
- Keywords > Extensively drug-resistant tuberculosis (XDR-TB)
- Keywords > guidelines
- Keywords > HAART (Highly Active Anti-Retroviral Therapy)
- Keywords > Multidrug-resistant Tuberculosis (MDR-TB)
- Keywords > TB/HIV (HIV-related TB)
(2008; 272 pages)
The emergence in 2006 of extensively drug-resistant strains of tuberculosis, especially in countries with a high prevalence of human immunodeficiency virus, is a serious threat to global public health that jeopardizes efforts to control the disease effectively.
This important development and the availability of new evidence related to the diagnosis and management of drug-resistant tuberculosis have mandated an urgent update of existing guidelines.
Guidelines for the programmatic management of drug-resistant tuberculosis: emergency updated edition 2008 replaces previous publications by the World Health Organization on this subject.
These guidelines offer updated recommendations for the diagnosis and management of drug-resistant tuberculosis in a variety of geographic, economic and social settings, as well as for the recording of data to enable the monitoring and evaluation of programmes.
Intended for use by both tuberculosis control programmes and medical practitioners in low-income and middle-income countries, the guidelines take into account a number of recommendations that will support the achievement by countries of the goals of the Global Plan to Stop TB 2006–2015 of the Stop TB Partnership.